MD Anderson Cancer Center

Average: 5 (1 vote)

The Director of the NDC, William J. Ray, Ph.D, coordinates research activities across the member institutions. MD Anderson’s Institute for Applied Cancer Science (IACS) which is the drug discovery and development arm of the NDC is led by Giulio Draetta, M.D., Ph.D., professor of genomic medicine and director of IACS and Philip Jones, Ph.D., executive director and head of drug discovery of IACS. Ron DePinho, M.D., founder of the NDC and the President of the University of Texas MD Anderson Cancer Center, is also an active Principal Investigator of the NDC.